These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38705689)

  • 1. What's New on the Street?: An Update on New Opioids, Psychoactive Drugs, and Synthetic Marijuana.
    Harris-Haman PA
    Crit Care Nurs Clin North Am; 2024 Jun; 36(2):211-221. PubMed ID: 38705689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New and Emerging Illicit Psychoactive Substances.
    Graddy R; Buresh ME; Rastegar DA
    Med Clin North Am; 2018 Jul; 102(4):697-714. PubMed ID: 29933824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Going beyond prescription pain relievers to understand the opioid epidemic: the role of illicit fentanyl, new psychoactive substances, and street heroin.
    Pergolizzi JV; LeQuang JA; Taylor R; Raffa RB;
    Postgrad Med; 2018 Jan; 130(1):1-8. PubMed ID: 29190175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of pregnancy on psychoactive substance use among women with substance use disorders recruited in addiction specialized care centers in France.
    Pochard L; Dupouy J; Frauger E; Giocanti A; Micallef J; Lapeyre-Mestre M;
    Fundam Clin Pharmacol; 2018 Apr; 32(2):188-197. PubMed ID: 29337399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature.
    Chiappini S; Mosca A; Miuli A; Santovito MC; Orsolini L; Corkery JM; Guirguis A; Pettorruso M; Martinotti G; Di Giannantonio M; Schifano F
    Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34204131
    [No Abstract]   [Full Text] [Related]  

  • 6. Designer drugs: a medicinal chemistry perspective (II).
    Carroll FI; Lewin AH; Mascarella SW; Seltzman HH; Reddy PA
    Ann N Y Acad Sci; 2021 Apr; 1489(1):48-77. PubMed ID: 32396701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal drug use and its effect on neonates: a population-based study in Washington State.
    Creanga AA; Sabel JC; Ko JY; Wasserman CR; Shapiro-Mendoza CK; Taylor P; Barfield W; Cawthon L; Paulozzi LJ
    Obstet Gynecol; 2012 May; 119(5):924-33. PubMed ID: 22525903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance abuse during pregnancy.
    Wheeler SF
    Prim Care; 1993 Mar; 20(1):191-207. PubMed ID: 8464941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The health threat of new synthetic opioids as adulterants of classic drugs of abuse.
    Rinaldi R; Negro F; Minutillo A
    Clin Ter; 2020; 171(2):e107-e109. PubMed ID: 32141480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Psychoactive substance use during pregnancy: a review].
    Lamy S; Thibaut F
    Encephale; 2010 Feb; 36(1):33-8. PubMed ID: 20159194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study.
    Huybrechts KF; Bateman BT; Desai RJ; Hernandez-Diaz S; Rough K; Mogun H; Kerzner LS; Davis JM; Stover M; Bartels D; Cottral J; Patorno E
    BMJ; 2017 Aug; 358():j3326. PubMed ID: 28768628
    [No Abstract]   [Full Text] [Related]  

  • 12. Neonatal drug withdrawal.
    Hudak ML; Tan RC; ; ;
    Pediatrics; 2012 Feb; 129(2):e540-60. PubMed ID: 22291123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview and epidemiology of substance abuse in pregnancy.
    Wendell AD
    Clin Obstet Gynecol; 2013 Mar; 56(1):91-6. PubMed ID: 23314721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytically confirmed illicit and novel psychoactive drug use in Western Australian emergency departments: initial results from the Emerging Drugs Network of Australia (EDNA).
    Weber C; Smith JL; Soderstrom J; Burrows S; McCutcheon D; Oosthuizen F; Fatovich DM;
    Clin Toxicol (Phila); 2023 Jul; 61(7):500-508. PubMed ID: 37449677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Illicit drug use among pregnant women enrolled in treatment for cigarette smoking cessation.
    Gaalema DE; Higgins ST; Pepin CS; Heil SH; Bernstein IM
    Nicotine Tob Res; 2013 May; 15(5):987-91. PubMed ID: 23072871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of the effects of novel psychoactive substances 'legal highs' on people with severe mental illness.
    Gray R; Bressington D; Hughes E; Ivanecka A
    J Psychiatr Ment Health Nurs; 2016 Jun; 23(5):267-81. PubMed ID: 27037639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New psychoactive substances: An actual problem or an overestimated phenomenon?
    Vaiano F; Pascali JP; Bertol E
    Forensic Sci Int; 2019 Nov; 304():109941. PubMed ID: 31574421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lifetime prevalence of novel psychoactive substances use among adults in the USA: Sociodemographic, mental health and illicit drug use correlates. Evidence from a population-based survey 2007-2014.
    Neicun J; Yang JC; Shih H; Nadella P; van Kessel R; Negri A; Czabanowska K; Brayne C; Roman-Urrestarazu A
    PLoS One; 2020; 15(10):e0241056. PubMed ID: 33125395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The challenge of the novel psychoactive substances: How have we responded and what are the implications of this response?
    Wood DM; Dargan PI
    Br J Clin Pharmacol; 2020 Mar; 86(3):407-409. PubMed ID: 32144815
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of drug abuse on pregnancy.
    Kuczkowski KM
    Curr Opin Obstet Gynecol; 2007 Dec; 19(6):578-85. PubMed ID: 18007137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.